Skip to content Skip to footer
Subscribe Now
VIEWPOINTS

Breaking New Ground in Oncology: Leonard Mazur from Citius Pharmaceuticals in Conversation with PharmaShots 

Shots:   Citius Pharmaceuticals celebrates its first-ever FDA approval with Lymphir, a novel therapy for relapsed or refractory cutaneous T-cell lymphoma     In an exclusive conversation, Leonard Mazur, Co-Founder and CEO at Citius Pharmaceuticals, shares insights on Lymphir’s launch strategy and its potential impact on the oncology landscape    Leonard also highlights Mino-Lok, Citius’ innovative…
October 6, 2025

Read more

EVENTS

Discovery & Development Summit Asia 2025

Discovery & Development Summit Asia 2025 is Global Engage’s inaugural platform that brings together the Drug Discovery & Development, Nucleic Acid Therapeutics and Precision Medicine congresses. This summit allows the exploration of the full spectrum of therapeutic innovation, from early-stage discovery to clinical translation and commercialization. Attendees will gain insights into assay development, screening technologies,…
August 5, 2025

Read more

THOUGHTSPOT

Precision Medicine in Cancer Treatment: Revolutionizing Patient Care Through Personalized Approaches

Precision medicine has emerged as a transformative approach in cancer treatment, moving away from the traditional one-size-fits-all methodology toward highly individualized therapeutic strategies. This paradigm shift recognizes that each patient's cancer is unique, with distinct genetic profiles, molecular characteristics, and treatment responses that require tailored approaches. By leveraging advanced genomic technologies, biomarker identification, and sophisticated…
June 24, 2025

Read more

Viewpoints_Anton Yarovoy
VIEWPOINTS

Driving Precision Medicine Education: A Star Wars-Themed Talk on a Needed Approach

Shots:    Precision Medicine is a rapidly evolving field offering targeted treatments for optimal patient care    Education around testing is a critical need as many barriers exist that create practice gaps to patient identification   Testing State Awareness (TSA) is a critical component that needs to complement Brand and Disease State Awareness campaigns    Anton Yarovoy, Group Product…
April 18, 2025

Read more

e-Brain OncoVision Connecting the Dots in Cancer Care
EVENTS

e-Brain OncoVision: Connecting the Dots in Cancer Care

Gear up for the most awaited metaverse-based global event!  Don’t miss out on this enlightening conference focussed on Oncology domains by Ingenious E-Brain.  The virtual event “e-Brain OncoVision: Connecting the Dots in Cancer Care” is scheduled for February 15th (9:00AM EST) to February 16th, 2024 (5:30PM EST)  Featuring renowned speakers from leading biopharma companies & organizations, the…
January 18, 2024

Read more

PharmaShots Interview Myriad Genetics’ Todd Cohen Shares Insights on the Trends in Prostate Cancer and Precision Medicine
VIEWPOINTS

PharmaShots Interview: Myriad Genetics’ Todd Cohen Shares Insights on the Trends in Prostate Cancer and Precision Medicine

In an interview with PharmaShots, Todd Cohen, MD, Vice President of Medical Affairs/Medical Director of Urology at Myriad Genetics shares his views on the precision medicine and prognostic tests for Prostate Cancer Shots: The company reported the importance of precision medicine and prognostic tests that can help to determine cancer & enables personalized treatment paths. The company highlights the ability of genetic…
February 9, 2022

Read more

Viewpoints_Dr. Minnie Sarwal
VIEWPOINTS

PharmaShots Interview: NephroSant’s Dr. Minnie Sarwal Shares Insights on QSant and the Need for Precision Medicine in Kidney Health

In an interview with PharmaShots, Dr. Minnie Sarwal, CEO and Co-Founder of NephroSant shares her view on the QSant and how this urine test can improve outcomes for transplant patients. She also shed light on the need for precision therapies in kidney transplant care. Shots: NephroSant's Qsant is a needle-free urine test that helps in determining if…
July 7, 2021

Read more